-+ 0.00%
-+ 0.00%
-+ 0.00%

Wolfe Research Upgrades Kymera Therapeutics to Outperform

Benzinga·09/10/2026 13:36:06
语音播报
Wolfe Research analyst Andy Chen upgrades Kymera Therapeutics (NASDAQ:KYMR) from Peer Perform to Outperform.